Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析

◆英語タイトル:Clearside BioMedical Inc (CLSD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME378786FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO – Retinal Vein Occlusion and DME – Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearside’s proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc Key Recent Developments

Apr 05,2021: Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
Mar 10,2021: Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Feb 24,2021: Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday, March 10, 2021
Nov 10,2020: Clearside Biomedical announces third quarter 2020 financial results and provides corporate update
Sep 23,2020: Clearside Biomedical announces clinical data presentations at The Retina Society 2020 and publication of XIPERE data in diabetic macular edema in Ophthalmology Retina

This comprehensive SWOT profile of Clearside BioMedical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Clearside BioMedical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Clearside BioMedical Inc – Key Information
Clearside BioMedical Inc – Overview
Clearside BioMedical Inc – Key Employees
Clearside BioMedical Inc – Key Employee Biographies
Clearside BioMedical Inc – Key Operational Heads
Clearside BioMedical Inc – Major Products and Services
Clearside BioMedical Inc – History
Clearside BioMedical Inc – Company Statement
Clearside BioMedical Inc – Locations And Subsidiaries
Clearside BioMedical Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Clearside BioMedical Inc – Business Description
Clearside BioMedical Inc – Corporate Strategy
Clearside BioMedical Inc – SWOT Analysis
SWOT Analysis – Overview
Clearside BioMedical Inc – Strengths
Clearside BioMedical Inc – Weaknesses
Clearside BioMedical Inc – Opportunities
Clearside BioMedical Inc – Threats
Clearside BioMedical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Clearside BioMedical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Clearside BioMedical Inc, Key Information
Clearside BioMedical Inc, Key Ratios
Clearside BioMedical Inc, Share Data
Clearside BioMedical Inc, Major Products and Services
Clearside BioMedical Inc, History
Clearside BioMedical Inc, Key Employees
Clearside BioMedical Inc, Key Employee Biographies
Clearside BioMedical Inc, Key Operational Heads
Clearside BioMedical Inc, Other Locations
Clearside BioMedical Inc, Subsidiaries
Clearside BioMedical Inc, Key Competitors
Clearside BioMedical Inc, SWOT Analysis
Clearside BioMedical Inc, Ratios based on current share price
Clearside BioMedical Inc, Annual Ratios
Clearside BioMedical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業の財務・戦略的SWOT分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company that manufactures and markets medicinal products. The company provides operations such as domestic marketing, international marketing, international export and business development, among others. It offers products …
  • Computer Services, Inc (CSVI):企業の財務・戦略的SWOT分析
    Computer Services, Inc (CSVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Western Areas Limited:企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Damco International B.V.:企業の戦略・SWOT・財務分析
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fluidic Analytics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Fluidic Analytics Ltd (Fluidic Analytics) is a biotechnology company that offers diagnostic tools to sequence and characterize proteins in laboratory, medical and consumer applications. The company offers Flow Mk-1 and Flow Mk-2 products. Flow Mk-1 is a lab instrument, which comprises dispos …
  • Algonquin Power & Utilities Corp:企業の発電所・SWOT分析2018
    Algonquin Power & Utilities Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • PanOptica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PanOptica Inc (PanOptica) is a clinical-stage biopharmaceutical company that develops topical eye drops for the treatment of sight-threatening eye diseases. The company concentrates on candidates that are at or near the investigational new drug application stage. It develops PAN-90806, a nov …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • FAR Ltd (FAR):企業の財務・戦略的SWOT分析
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Phoenix Petroleum Philippines Inc (PNX):企業の財務・戦略的SWOT分析
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Largo Resources Ltd.:企業のM&A・事業提携・投資動向
    Largo Resources Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Largo Resources Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Foundation Medicine Inc (FMI)-医療機器分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Genworth Financial, Inc.:企業の戦略・SWOT・財務情報
    Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Heliatek GmbH-エネルギー分野:企業M&A・提携分析
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Waterstone Financial Inc (WSBF):企業の財務・戦略的SWOT分析
    Waterstone Financial Inc (WSBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Wirecard AG:企業の戦略・SWOT・財務分析
    Wirecard AG - Strategy, SWOT and Corporate Finance Report Summary Wirecard AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kwality Group
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MOIL Limited:企業の戦略・SWOT・財務情報
    MOIL Limited - Strategy, SWOT and Corporate Finance Report Summary MOIL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆